Latest news
Avalo Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocusGuruFocus · Sat, 08 Aug 2026 22:59:00 GMTBank of America Securities Reaffirms Their Buy Rating on Avalo Therapeutics (AVTX) - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 10:59:00 GMTA Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $30 to $58 - MoomooMoomoo · Fri, 07 Aug 2026 19:56:38 GMTAVTX Maintains Buy Rating by Guggenheim -- Price Target Lowered to $48 - GuruFocusGuruFocus · Fri, 07 Aug 2026 19:15:45 GMTAVTX Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocusGuruFocus · Fri, 07 Aug 2026 14:33:10 GMTState Street Corporation (NYSE: AVTX custodian) discloses 5.5% Avalo stake - stocktitan.netstocktitan.net · Fri, 07 Aug 2026 12:44:31 GMTAVTX SWOT Analysis: Financial Challenges and Promising Pipeline Revealed in 10-Q Filing - GuruFocusGuruFocus · Fri, 07 Aug 2026 08:03:26 GMTPrice-Driven Insight from (AVTX) for Rule-Based Strategy - Stock Traders DailyStock Traders Daily · Thu, 06 Aug 2026 23:20:02 GMT